NCT02766933Completed
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Source: ClinicalTrials.gov · Last updated 20 Jan 2025
Brief summary (registry, in English)
The natural history and response to therapy of chronic hepatitis B infection in West Africa are currently poorly understood. In this study, employees of the Cameroon Baptist Convention Health Board (CBCHB) and spouses who are found to be hepatitis B positive on screening will be offered enrollment. Disease monitoring and treatment will be provided following current WHO guidelines. Clinical data will be prospectively recorded for 5 years, and bio-specimens will be frozen for future analysis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 207 (actual)
- First submitted
- 20 Apr 2016
- Start date
- 1 May 2016
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Mayo Clinic
- NCT number
- NCT02766933
What you commit to
- Study type: Observational
- Participants enrolled: 207
- From 1 May 2016 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Age at least 18yrs.
- CBCHB employee or spouse of an employee.
- Able to provide written informed consent.
- Willing to comply with follow-up visits.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mbingo Baptist Hospital Coordinator of this site? Confirm its status | Bamenda | Cameroon | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.